The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(pyrazolo[1,5-a]pyrimidin-3-yl)quinoline ID: ALA512294
Chembl Id: CHEMBL512294
PubChem CID: 44577771
Max Phase: Preclinical
Molecular Formula: C15H10N4
Molecular Weight: 246.27
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc2c(-c3cnn4cccnc34)ccnc2c1
Standard InChI: InChI=1S/C15H10N4/c1-2-5-14-12(4-1)11(6-8-16-14)13-10-18-19-9-3-7-17-15(13)19/h1-10H
Standard InChI Key: TWMAPZXJXKGZOT-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 246.27Molecular Weight (Monoisotopic): 246.0905AlogP: 2.94#Rotatable Bonds: 1Polar Surface Area: 43.08Molecular Species: NEUTRALHBA: 4HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.45CX LogP: 2.46CX LogD: 2.46Aromatic Rings: 4Heavy Atoms: 19QED Weighted: 0.52Np Likeness Score: -1.48
References 1. Cuny GD, Yu PB, Laha JK, Xing X, Liu JF, Lai CS, Deng DY, Sachidanandan C, Bloch KD, Peterson RT.. (2008) Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors., 18 (15): [PMID:18621530 ] [10.1016/j.bmcl.2008.06.052 ]